Daniel Duk-ki Moon
Biography
Daniel Duk-ki (pronounced “duck key”) Moon serves as a trusted advisor to U.S. and international clients in all phases of U.S. and multijurisdictional merger review processes and advises on a broad range of antitrust and regulatory issues related to both domestic and cross border mergers and acquisitions, joint ventures, and other business arrangements, including notifications and clearances under the Hart-Scott-Rodino Act. He also counsels clients on compliance and enforcement issues related to cartels, vertical restraints, market manipulation, hub-and-spoke liability, and other antitrust law matters.
With a reputation for delivering practical, business-oriented solutions, Duk-ki leverages his experience working on bet-the-company mergers and managing multijurisdictional remedies negotiations to strike the balance between managing regulatory demands all while prioritizing the client’s commercial drivers.
Practice Focus
Duk-ki has particular expertise in the pharmaceuticals industry and has helped leading multinational companies with various transactions and antitrust matters but also has strong credentials across a wide variety of industries, such as health insurance, heavy machinery, mining, oil and gas, healthcare, technology, chemicals, mining, technology, fintech, and agriculture.
Representative Legal Matters
Duk-ki has advised clients on a wide range of antitrust matters (both prior to and at Baker McKenzie), including:
- Owens Corning on its approximately USD 755 million global divestiture of its glass reinforcement business to Praana Group
- Lyft on its EUR 175 million acquisition of Freenow
- H. Lundbeck A/S on its approximately USD 2.5 billion acquisition of Longboard Pharmaceuticals
- Bayer AG on its approximately USD 2 billion acquisition of Vividion Therapeutics, Inc.
- Numab Therapeutics on its approximately USD 1.25 billion sale of Yellow Jersey Therapeutics
- Galapagos NV on its approximately USD 5.1 billion collaboration with Gilead Sciences Inc.
- Bayer AG on its approximately USD 4 billion acquisition of Asklepios BioPharmaceutical, Inc.
- The Nielsen Company on its approximately USD 2.7 billion sale of Nielsen IǪ to Advent International
- ALDI in its acquisition of Southeastern Grocers, including the Winn-Dixie and Harveys Supermarket brands
- Sika AG on its approximately USD 6 billion acquisition of MBCC Group
- Novartis on various antitrust matters, including its series of transactions with GlaxoSmithKline
- Western Refining, Inc. on its acquisition by Tesoro Corporation before the Federal Trade Commission
- Wellpoint (now Anthem) on various antitrust matters, including its acquisition of Amerigroup
- Glencore plc on its merger with Xstrata before the DOJ
- Actavis Group on its EUR 4.25 billion sale to Watson Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company on various antitrust matters, including its USD 62 billion acquisition of Shire plc
Professional Honors
- Future Leader, Lexology Competition Index (formerly Who’s Who Legal) (2023, 2024, 2025)
Professional Associations and Memberships
- American Bar Association - Member, Antitrust section
- National Asian Pacific American Bar Association - Member
- Asian Pacific American Bar Association, DC - Member
Admissions
- New York~United States (2013)
Education
- Yeshiva University (JD) (2011)
- Berklee College of Music (BA) (2007)
Languages
- English
- Korean